Literature DB >> 27211077

Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort.

Adriano Alatri1, Alain Schoepfer2, Nicolas Fournier3, Rolf Peter Engelberger1, Ekaterina Safroneeva4, Stephan Vavricka5,6, Luc Biedermann6, Luca Calanca1, Lucia Mazzolai1.   

Abstract

OBJECTIVE: Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is associated with the occurrence of venous thromboembolism (VTE) such as deep vein thrombosis (DVT) and pulmonary embolism (PE). We aimed to assess the prevalence and associated risk factors for VTE in a large national cohort of IBD patients.
MATERIAL AND METHODS: Data from patients of the Swiss IBD Cohort Study (SIBDCS) enrolled between 2006 and 2013 were analyzed.
RESULTS: A total of 2284 IBD patients were analyzed of which 1324 suffered from CD and 960 from UC. VTE prevalence was 3.9% (90/2284) overall and 3.4% (45/1324) in CD patients (whereof 2.4% suffered from DVT and 1.5% from PE) and 4.7% (45/960) in UC patients (whereof 3.2% suffered from DVT and 2.4% from PE). Median disease duration in CD patients with VTE was 12 years [IQR 8-23] compared to eight years [3-16] in CD patients without VTE (p = 0.001). Disease duration in UC patients with VTE was seven years [4-18] compared to six years [2-13] in UC patients without VTE (p = 0.051). Age at CD diagnosis ≥40 years (OR 1.851, p = 0.073) and disease duration >10 years (OR 1.771, p = 0.088) showed a trend to be associated with VTE. In UC patients, IBD-related surgery (OR 3.396, p = 0.004) and pancolitis (OR 1.927, p = 0.050) were significantly associated with VTE.
CONCLUSIONS: VTE are prevalent in CD and UC patients. Pancolitis and UC-related surgery are significantly associated with VTE in UC patients.

Entities:  

Keywords:  Crohn's disease; thromboembolic complications; ulcerative colitis; venous thromboembolism

Mesh:

Year:  2016        PMID: 27211077     DOI: 10.1080/00365521.2016.1185464

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  11 in total

1.  Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease.

Authors:  Mikihiro Fujiya; Tsutomu Kawaguchi; Shoko Arai; Naoki Isogawa; Shintaro Hiro; Fumihiro Matsumoto; Satoshi Yamaguchi; Noritoshi Yoshii; Mashio Nakamura; Katsuyoshi Matsuoka
Journal:  Dig Dis Sci       Date:  2022-02-12       Impact factor: 3.487

2.  Preferences Regarding Shared Decision-Making in Japanese Inflammatory Bowel Disease Patients.

Authors:  Ryuji Morishige; Hiroshi Nakajima; Kazutake Yoshizawa; Jörg Mahlich; Rosarin Sruamsiri
Journal:  Adv Ther       Date:  2016-11-02       Impact factor: 3.845

3.  Inflammatory Bowel Disease Adversely Impacts Colorectal Cancer Surgery Short-term Outcomes and Health-Care Resource Utilization.

Authors:  Mitchell Ramsey; Somashekar G Krishna; Peter P Stanich; Syed Husain; Edward J Levine; Darwin Conwell; Alice Hinton; Cheng Zhang
Journal:  Clin Transl Gastroenterol       Date:  2017-11-30       Impact factor: 4.488

4.  The incidence and risk factors of venous thromboembolism in Japanese inpatients with inflammatory bowel disease: a retrospective cohort study.

Authors:  Katsuyoshi Ando; Mikihiro Fujiya; Yoshiki Nomura; Yuhei Inaba; Yuuya Sugiyama; Takuya Iwama; Masami Ijiri; Keitaro Takahashi; Kazuyuki Tanaka; Aki Sakatani; Nobuhiro Ueno; Shin Kashima; Kentaro Moriichi; Yusuke Mizukami; Toshikatsu Okumura
Journal:  Intest Res       Date:  2018-07-27

Review 5.  Cardiovascular Manifestations of Inflammatory Bowel Disease: Pathogenesis, Diagnosis, and Preventive Strategies.

Authors:  Diana-Maria Bunu; Cristian-Eugen Timofte; Manuela Ciocoiu; Mariana Floria; Claudia-Cristina Tarniceriu; Oana-Bogdana Barboi; Daniela-Maria Tanase
Journal:  Gastroenterol Res Pract       Date:  2019-01-13       Impact factor: 2.260

6.  The risk of venous thromboembolism in women with inflammatory bowel disease during pregnancy and the postpartum period: A systematic review and meta-analysis.

Authors:  Yeon Hee Kim; Birgit Pfaller; Alanna Marson; Hyeon Woo Yim; Vivian Huang; Shinya Ito
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

Review 7.  Venous thromboembolism in inflammatory bowel disease.

Authors:  Kimberly Cheng; Adam S Faye
Journal:  World J Gastroenterol       Date:  2020-03-28       Impact factor: 5.742

8.  Impaired Coagulation Status in the Crohn's Disease Patients Complicated with Intestinal Fistula.

Authors:  Yuan Li; Jian-An Ren; Ge-Fei Wang; Guo-Sheng Gu; Xiu-Wen Wu; Song Liu; Hua-Jian Ren; Zhi-Wu Hong; Jie-Shou Li
Journal:  Chin Med J (Engl)       Date:  2018-03-05       Impact factor: 2.628

9.  Hemophilia A Complicated by Ulcerative Colitis.

Authors:  Maxim Olivier; Mario Madruga; S J Carlan; Li Ge
Journal:  Case Rep Gastrointest Med       Date:  2018-09-04

10.  Epidemiology and Risk Factors of Portal Venous System Thrombosis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Authors:  Hanyang Lin; Zhaohui Bai; Fanjun Meng; Yanyan Wu; Li Luo; Akash Shukla; Eric M Yoshida; Xiaozhong Guo; Xingshun Qi
Journal:  Front Med (Lausanne)       Date:  2022-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.